Financhill
Back

Verizon Communications, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
35

VZ
Verizon Communications, Inc.

Last Price:
$39.92
Seasonality Move:
0.9%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Sell
35
Verizon Communications, Inc. (VZ) is a Sell

Is Verizon Communications, Inc. a Buy, Sell or Hold?

  • The current Verizon Communications, Inc. [VZ] share price is $39.98. The Score for VZ is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • VZ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VZ Stock Price Chart

What is Verizon Communications, Inc.'s stock price today?

  • The Verizon Communications, Inc. share price today is $39.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

VZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.93 Buy
Relative Strength Index (14 RSI): 43.59 Sell
Chaikin Money Flow: 12666931 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.25 - 41.23) Sell
Bollinger Bands (100): (40.12 - 43.68) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

VZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.47 Sell
20-day SMA: 40.64 Sell
50-day SMA: 40.35 Sell
200-day SMA: 42.57 Sell
8-day EMA: 25.47 Buy
20-day EMA: 13.27 Buy
50-day EMA: 5.95 Buy
200-day EMA: 1.58 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Verizon Communications, Inc. Earnings Growth & VZ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.11 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Verizon Communications, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):